Package 51316-993-36

{"route": ["ORAL"], "spl_id": "85bd100e-7bbc-4ab0-9f19-e119a28f16d3", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1305603"], "spl_set_id": ["4dee850b-b170-4ef9-ae02-3db9bfa05abe"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["CVS Pharmacy, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (51316-993-18)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51316-993-18", "marketing_start_date": "20210506"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (51316-993-36)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51316-993-36", "marketing_start_date": "20210506"}], "brand_name": "Guaifenesin D", "product_id": "51316-993_85bd100e-7bbc-4ab0-9f19-e119a28f16d3", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "51316-993", "generic_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "labeler_name": "CVS Pharmacy, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin D", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "ANDA212542", "marketing_category": "ANDA", "marketing_start_date": "20210506", "listing_expiration_date": "20261231"}